22 related articles for article (PubMed ID: 10919343)
1. Long-term and per rectum disposition of Clarithromycin in the desert tortoise (Gopherus agassizii).
Wimsatt J; Tothill A; Offermann CF; Sheehy JG; Peloquin CA
J Am Assoc Lab Anim Sci; 2008 Jul; 47(4):41-5. PubMed ID: 18702450
[TBL] [Abstract][Full Text] [Related]
2. Simple Determination of Bosentan in Plasma Samples by Reversed-Phase High-Performance Liquid Chromatography.
Abbasi N
Avicenna J Med Biotechnol; 2024; 16(2):104-110. PubMed ID: 38618512
[TBL] [Abstract][Full Text] [Related]
3. Average bioequivalence study of clarithromycin tablets in healthy male volunteers.
Lohitnavy M; Lohitnavy O; Sareekan K; Chaiyaput W
J Clin Pharm Ther; 2003 Jun; 28(3):187-90. PubMed ID: 12795777
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence study of two oral formulations of clarithromycin in human male subjects.
Khan MK; Khan MF; Mustafa G; Sualah M
Pak J Pharm Sci; 2011 Jan; 24(1):43-6. PubMed ID: 21190917
[TBL] [Abstract][Full Text] [Related]
5. Human Bioequivalence Study of Clarithromycin from Two Tablet Formulations after Single Oral Administration.
Niopas I; Daftsios AC; Nikolaidis N
Clin Drug Investig; 2001 Mar; 21(3):211-7. PubMed ID: 27517551
[TBL] [Abstract][Full Text] [Related]
6. A survey of the quality of generic clarithromycin products from 18 countries.
Nightingale CH
Clin Drug Investig; 2005; 25(2):135-52. PubMed ID: 17523763
[TBL] [Abstract][Full Text] [Related]
7. Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers.
Lohitnavy M; Lohitnavy O; Wittaya-areekul S; Sareekan K; Polnok S; Chaiyaput W
Drug Dev Ind Pharm; 2003 Jul; 29(6):653-9. PubMed ID: 12889783
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers.
Lerner FE; Caliendo G; Santagada V; Santana GSM ; Moraes MEA ; De Nucci G
Int J Clin Pharmacol Ther; 2000 Jul; 38(7):345-54. PubMed ID: 10919343
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine bioequivalence study: quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry.
Moraes MO; Lerner FE; Corso G; Bezerra FA; Moraes ME; De Nucci G
J Clin Pharmacol; 1999 Oct; 39(10):1053-61. PubMed ID: 10516940
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole bioequivalence study: quantification by tandem mass spectrometry.
Moraes LA; Lerner FE; Moraes ME; Moraes MO; Corso G; De Nucci G
Ther Drug Monit; 1999 Apr; 21(2):200-7. PubMed ID: 10217340
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers.
Ruenis AP; Moreno RA; Abib-Júnior E; Simões RP; Franco LM; Groppo FC; Baglie S; Franco GC; Rosalen PL
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):399-404. PubMed ID: 16119515
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
